Major Considerations and Outcomes of Clinical Studies on Vitamin D Deficiency in Patients with Crohn's

Image

Major Considerations and Outcomes of Clinical Studies on Vitamin D Deficiency in Patients with Crohn's

Introduction: The literature shows a bimodal incidence of Crohn's disease in relation to age, with peaks from 15-40 and from 50-80 years and more women have Crohn's disease than men. Clinical studies have shown a direct correlation of vitamin D deficiency with Crohn's disease.

Objective: Using a systematic review, the objective of this study was to identify the main correlations and outcomes of clinical studies about vitamin D in Crohn's disease.

Methods: Following the rules for systematic reviews (PRISMA), the key search terms used were Crohn’s disease, vitamin D, clinical studies, immunotherapy and quality of life. After applying exclusion criteria, 117 articles were included and discussed in this study.

Conclusion: The prevalence of low serum vitamin D levels has been demonstrated in patients suffering from Crohn's disease. However, further studies that are more comprehensive are still needed, in particular investigations that aim to evaluate the effects of serum vitamin D levels on clinical treatment and the effects of vitamin D supplementation on disease activity and mucosal healing. Thus, it may be possible to optimize the treatment of Crohn's disease patients thereby improving their quality of life.

To know more about the article: https://www.longdom.org/archive/imr-volume-14-issue-3-year-2018.html

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.longdom.org/submissions/immunome-research.html) or forwarded to the Editorial Office at: [email protected]

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Stella M
Journal Manager
Immunome Research
Email: [email protected]